Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.30 USD
Change Today 0.00 / 0.00%
Volume 0.0
PBSV On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

pharma-bio serv inc (PBSV) Snapshot

Open
$1.30
Previous Close
$1.30
Day High
$1.30
Day Low
$1.30
52 Week High
04/4/14 - $1.93
52 Week Low
06/25/14 - $0.80
Market Cap
30.0M
Average Volume 10 Days
6.6K
EPS TTM
$0.09
Shares Outstanding
23.1M
EX-Date
--
P/E TM
15.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMA-BIO SERV INC (PBSV)

Related News

No related news articles were found.

pharma-bio serv inc (PBSV) Related Businessweek News

No Related Businessweek News Found

pharma-bio serv inc (PBSV) Details

Pharma-Bio Serv, Inc. provides technical compliance consulting services, and microbiological and chemical laboratory testing services. The company’s technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. It also offers various information technology services, including Web pages and portals development; digital art design; intranets; extranets; software development that includes database integration; Windows and Web applications development; software technical training and learning management systems; technology project management; compliance consulting services; and others. In addition, the company provides microbiological testing services and chemical testing services through its laboratory; and technical trainings/seminars. It markets its services through industry trade shows, professional conventions, industry publications, and seminars in Puerto Rico, the United States, and Europe. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

205 Employees
Last Reported Date: 01/29/15
Founded in 1993

pharma-bio serv inc (PBSV) Top Compensated Officers

Founder, Chairman, Senior Strategic Consultan...
Total Annual Compensation: --
Chief Financial Officer, Vice President of Fi...
Total Annual Compensation: $158.4K
Compensation as of Fiscal Year 2014.

pharma-bio serv inc (PBSV) Key Developments

Pharma-Bio Serv, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2015

Pharma-Bio Serv, Inc. reported earnings results for the first quarter ended January 31, 2015. For the quarter, the company reported net revenues for the three months ended January 31, 2015 were $5.9 million, a decrease of approximately $1.1 million, or 16%, when compared to the same period last year. This decline is mainly attributable to a $1.5 and $0.3 million revenue decrease in the United States and Europe consulting markets, respectively, offset by a gain in the Puerto Rico consulting business of approximately $0.7 million, of which $0.4 million are attributable to projects in Latin America that are managed from Puerto Rico. Other Company divisions sustained minor revenue gains/losses or remained constant, when compared to the same period last year. Net income was approximately $0.3 million, a decrease of $0.4 million when compared with the same period last year. Net income variance, when compared to the same period last year, is mainly attributable to the decline in revenue, offset by a reduction of business development and operational support expenses, and the effect of the effective income tax rates over income before tax. For the three months ended January 31, 2015, earnings per common share, basic and diluted, were $0.013 and $0.012, respectively, a decrease of $0.016 for both, when compared to the same period last year. The decrease is mainly attributable to the decrease in net income.

Pharma-Bio Serv, Inc. Announces Earnings Results for the Year Ended October 31, 2014

Pharma-Bio Serv, Inc. announced earnings results for the year ended October 31, 2014. For the year, the company reported total net revenues of $27.6 million for the year ended October 31, 2014, a decrease of approximately $5.5 million, or 16.7%, when compared to the same period last year. The revenue decrease is mainly attributable to a decline from consulting projects in the United States and Europe. Net income for year ended October 31, 2014 was approximately $2.4 million, a decrease of $2.5 million when compared to the same period last year. The decrease was mainly attributable to the decline in revenue, the increase in selling general and administrative expenses, and operations investments incurred to diversify markets, services and customer base, and the impact of the effective income tax rates (including Puerto Rico favorable tax grants) over income before tax.

Pharma-Bio Serv, Inc. to Report Q4, 2014 Results on Jan 29, 2015

Pharma-Bio Serv, Inc. announced that they will report Q4, 2014 results on Jan 29, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PBSV:US $1.30 USD 0.00

PBSV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PBSV.
View Industry Companies
 

Industry Analysis

PBSV

Industry Average

Valuation PBSV Industry Range
Price/Earnings 15.1x
Price/Sales 1.1x
Price/Book 1.5x
Price/Cash Flow 14.7x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMA-BIO SERV INC, please visit www.pharmabioserv.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.